"10.1371_journal.pone.0019461","plos one","2011-05-13T00:00:00Z","Francisco M Codoñer; Christian Pou; Alexander Thielen; Federico García; Rafael Delgado; David Dalmau; Miguel Álvarez-Tejado; Lidia Ruiz; Bonaventura Clotet; Roger Paredes","Institut de Recerca de la SIDA irsiCaixa-HIVACAT, Badalona, Spain; Unitat VIH, Hospital Universitari Germans Trias I Pujol, Badalona, Spain; Max Planck Institute für Informatik, Saarbücken, Germany; Hospital San Cecilio, Granada, Spain; Hospital 12 de Octubre, Madrid, Spain; Hospital Universitari Mutua Terrassa, Terrassa, Spain; Roche Diagnostics SL, Sant Cugat del Vallès, Spain","Conceived and designed the experiments: LR BC RP. Performed the experiments: FMC CP RP. Analyzed the data: FMC AT RP. Contributed reagents/materials/analysis tools: FMC AT FG RD DD MA-T LR BC RP. Wrote the paper: FMC CP RP. Contributed to the study design: FG RD DD MA-T.","F. García has been a consultant on advisory boards, or has participated in speakers' bureaus, with Roche, Boehringer-Ingelheim, BMS, GSK, Gilead, Janssen, Merck and Pfizer. R. Delgado has received consulting fees and grant support from Abbott, BMS, Gilead and Roche. D. Dalmau has been a consultant on advisory boards, has participated in speakers' bureaus, or has conducted clinical trials with Roche, Boehringer-Ingelheim, Abbott, BMS, GSK, Gilead, Tibotec, Janssen, Merck and Pfizer. M. Álvarez-Tejado works for Roche Diagnostics S.L., Spain, which commercializes the 454 sequencing technology in Spain. B. Clotet has been a consultant on advisory boards, has participated in speakers' bureaus, or has conducted clinical trials with Roche, Boehringer-Ingelheim, Abbott, BMS, GSK, Gilead, Tibotec, Janssen, Merck, Pfizer, Siemens, Monogram Biosciences, and Panacos. R. Paredes has received consulting fees from Pfizer and grant support from Pfizer, Siemens, Merck and Boehringer Ingelheim. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. F.M. Codoñer, C. Pou, A. Thielen, and L. Ruiz report no conflicts of interest relevant to this article. No other potential conflict of interest relevant to this article was reported.","2011","05","Francisco M Codoñer","FMC",10,TRUE,3,3,3,3,TRUE,TRUE,TRUE,1,"7",FALSE
